Search bioRxiv⌕ Search

Biology subjects

Csikos, K.

Publications and source records attributed to Csikos, K..

2 recordsLinked to original sources

Modular chronic cranial platform for longitudinal functional ultrasound, optical, and ECoG recording in a gyrencephalic model species

Understanding cortical function in large, gyrencephalic brains requires following the same tissue over time and interrogating it through complementary methods - yet in practice each recording modality is run on its own preparation, across separate animals and sessions that cannot be quantitatively related, while the recorded cortex can rarely be revisited. Functional ultrasound (fUS), widefield optical imaging, and electrocorticography (ECoG) are individually mature and strongly complementary, but no single preparation has combined all three within the same chronically accessible tissue in a gyrencephalic brain. Here we present a modular chronic cranial platform, validated in three cats with implants remaining functional for up to 3.3 years that unites these modalities in one customized chamber built around fUS as an anchor modality. The platform also supports fUS imaging in awake, head-unrestrained animals, with activation maps remaining spatially consistent across imaging days. By providing stable, quantitatively reproducible access to the same cortical region over time, this platform enables longitudinal, multimodal characterization of cortical function within individual subjects.

neuroscience↗

Pharmacokinetically optimized anesthesia enables long-term functional ultrasound imaging in the cat visual cortex

Functional ultrasound imaging (fUSI) measures cerebral blood-volume responses, so anesthesia protocols developed for BOLD fMRI may not preserve its signal. We screened three fMRI-derived anesthesia regimens for visually evoked fUSI in the cat visual cortex. Isoflurane-ketamine-medetomidine produced the strongest and most consistent responses, but the standard intramuscular medetomidine bolus suppressed the signal in one sensitive cat. Pharmacokinetic modeling guided replacement of this bolus with controlled intravenous dosing, restoring the visual response while maintaining physiological stability. The same weight-based regimen produced robust responses in the other animals. In a direct within-session test, response strength was equivalent in recordings separated by more than three hours. Across 464 recordings from 51 sessions in three cats, it showed no temporal drift during follow-up extending to 23 months. Visually evoked activation also remained clear relative to a small awake dataset, although equivalence was not established. PK-guided control of medetomidine exposure therefore enables stable, repeated fUSI of the cat visual cortex over hours to years.

neuroscience↗